Acrivastine

Acrivastine is a second-generation H1-receptor antagonist offering rapid-onset, largely non-sedating antihistamine activity, frequently combined with pseudoephedrine for allergy and cold-symptom relief. Simson Pharma's Acrivastine reference standard and impurities support assay and combination-product stability testing.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Acrivastine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Acrivastine
(Z)-3-(6-((E)-2-Carboxyvinyl)pyridin-2-yl)-3-(p-tolyl)acrylic Acid
(E)-3-(6-(1-Hydroxy-3-(pyrrolidin-1-yl)-1-(p-tolyl)propyl)pyridin-2-yl)acrylic Acid
1-((E)-3-(6-((E)-2-Carboxyvinyl)pyridin-2-yl)-3-(p-tolyl)allyl)pyrrolidine 1-oxide
(E)-2-bromo-6-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine
Ethyl (E)-3-(6-((E)-3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridin-2-yl)acrylate
2,3-Dihydro Acrivastine
Acrivastine Z-Isomer
Acrivastine Impurity 1
Acrivastine Impurity 2
Acrivastine Impurity 3
Acrivastine Impurity 4
Acrivastine Impurity 5
Acrivastine Impurity 6

Isotope Labelled Compounds

Acrivastine-D7
Acrivastine D8